Lymphoproliferative neoplasms are the most commonly identified underlying diseases in paraneoplastic pemphigus development, accounting for up to 84% of cases.

In adults, non-Hodgkin lymphoma is the most frequent underlying neoplasm (38.6%), followed by chronic lymphocytic leukemia (18.4%), and Castleman disease (18.4%).

Recently, researchers have identified increased susceptibility to paraneoplastic pemphigus development in patients with HLA Class II Drb1*03 allele